# Dow University of Health Sciences

Organization · id `cardio:org-dow-university-of-health-sciences` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 01h85hm56](<https://ror.org/01h85hm56>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 01h85hm56 by an exact name.

## The registry's words

- Sponsor name: Dow University of Health Sciences
- Sponsor class: OTHER
- ROR name: Dow University of Health Sciences

## Connected pages

- Sponsors: Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients. (`cardio:ct-nct02050529`)
- Sponsors: Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis (`cardio:ct-nct02169570`)
- Sponsors: Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy (`cardio:ct-nct03343366`)

## Provenance

Content hash: 7ac68fd9d89eea7d6c04abfce4dc4bd7e66ccc82f08b7c517f3b9e05ce8288d7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
